Loading…
P-356 Addition of SRL172 (Mycobacterium vaccae) to standard chemotherapy in small cell lung cancer (SCLC) confers no survival benefit: Results of a randomised multicentre study
Saved in:
Published in: | Lung cancer (Amsterdam, Netherlands) Netherlands), 2003-08, Vol.41, p.S181-S182 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 0169-5002 1872-8332 |
DOI: | 10.1016/S0169-5002(03)92324-5 |